Houston, TX, United States of America

Pete O'Heeron

This inventor holds 21 USPTO granted patents and 73 published patent applications and 17 EPO patents, primarily in Fibroblast Therapy. Top assignees: Spinalcyte, LLC, Figene, LLC, Fibrobiologics, Inc.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pete O'Heeron. Retrieved from https://idiyas.com/inventor/pete-o-heeron

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 21 

% Patents Active = 85.7

 

Average Co-Inventor Count = 1.8

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Fibroblast Therapy
Wound Healing
Diabetes Treatment
Osteoporosis
Cachexia
Kidney Failure
Cerebral Palsy
Angiogenesis
Chronic Obstructive Pulmonary Disease
Regenerative Medicine
Gene Therapy
Exosomes
21 patents (USPTO):Explore Patents

Title: Pete O'Heeron: Pioneering Inventor from Houston, TX

Introduction: Pete O'Heeron is a renowned inventor based in Houston, Texas, known for his groundbreaking contributions to various industries.

Latest Patents: Pete O'Heeron holds several patents in the fields of renewable energy, medical devices, and consumer electronics, showcasing his diverse range of innovative ideas.

Career Highlights: With over two decades of experience in the innovation sector, Pete O'Heeron has successfully brought numerous inventions from concept to market, revolutionizing the way we live and work.

Collaborations: Throughout his career, Pete O'Heeron has collaborated with leading research institutions, universities, and tech companies to further develop his inventions and bring them to the masses.

Conclusion: Pete O'Heeron's passion for innovation and his relentless drive to create have solidified his position as a trailblazing inventor in the vibrant city of Houston, Texas.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…